Literature DB >> 11309227

Current aspects of colchicine therapy -- classical indications and new therapeutic uses.

U Lange1, C Schumann, K L Schmidt.   

Abstract

Colchicine has been traditionally used for the treatment of gout. At present there is no generally accepted alternative to colchicine for the treatment of acute attacks or for the prevention of further attacks. The complex actions of this substance, which are mainly attributable to its stabilising action on the cytoskeleton and cell membranes, and its special pattern of distribution form the basis for the results presented here regarding the prophylactic or therapeutic actions of colchicine in a whole range of other diseases. This is all the more significant in that in several instances it concerns diseases that have so far been unsatisfactorily controlled by other treatments. Because of its astonishing absence of side effects, some authors consider that low dose colchicine may be considered as an alternative to previous therapies or even a means of first choice. It is therefore incorrect to think that medical research has shown little interest in this long-known potential and has not sought to confirm promising options by means of controlled studies. Fibrotic and inflammatory systemic diseases and those in which leucocytic chemotaxis play a role seem to be particularly predestined for this.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309227

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  10 in total

1.  The complete chloroplast genome of colchicine plants (Colchicum autumnale L. and Gloriosa superba L.) and its application for identifying the genus.

Authors:  Pham Anh Thi Nguyen; Jung Sung Kim; Joo-Hwan Kim
Journal:  Planta       Date:  2015-04-23       Impact factor: 4.116

Review 2.  New clinical trials in acute and recurrent pericarditis.

Authors:  Massimo Imazio
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 3.  Pathophysiology, clinical presentation and treatment of gout.

Authors:  Gim Gee Teng; Raj Nair; Kenneth G Saag
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Pericardial disease: diagnosis and management.

Authors:  Masud H Khandaker; Raul E Espinosa; Rick A Nishimura; Lawrence J Sinak; Sharonne N Hayes; Rowlens M Melduni; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

Review 5.  Management of gout in older adults: barriers to optimal control.

Authors:  Karl T Hoskison; Robert L Wortmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 6.  Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.

Authors:  Robert L Wortmann
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

7.  Colchicine-induced rhabdomyolysis.

Authors:  Arie Altman; Martine Szyper-Kravitz; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2007-07-10       Impact factor: 2.980

Review 8.  Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.

Authors:  José Luis Rosales-Alexander; Jerónimo Balsalobre Aznar; César Magro-Checa
Journal:  Open Access Rheumatol       Date:  2014-05-08

9.  Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.

Authors:  Khaled AbouAitah; Anna Swiderska-Sroda; Ahmed A Farghali; Jacek Wojnarowicz; Agata Stefanek; Stanislaw Gierlotka; Agnieszka Opalinska; Abdou K Allayeh; Tomasz Ciach; Witold Lojkowski
Journal:  Oncotarget       Date:  2018-05-29

Review 10.  Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.

Authors:  Eavan C McLoughlin; Niamh M O'Boyle
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.